Skip to main content

IMI impact on vaccines

How do IMI projects facilitate innovations in vaccine development and effectiveness assessment?

Doctor filling syringe with medication, closeup. Vaccination and immunization. Image by New Africa via Shutterstock
Doctor filling syringe with medication, closeup. Vaccination and immunization. Image by New Africa via Shutterstock

About vaccines in IMI projects

 

According to the World Health Organisation, vaccination prevents up to three million deaths per year worldwide.

IHI and IMI research projects have contributed successfully improve the R&D for the production of vaccines. According to public health organisations such as ECDC/US CDC. influenza vaccination is the most effective way to prevent influenza. There are already sign that the upcoming influenza season could be severe for vulnerable and elderly people, and that influenza patterns may vary between countries in terms of timing.

This webinar will present how IHI/IMI projects are: leading ongoing investigations for vaccine candidates for various diseases such as flu or pertussis; creating tools for monitoring vaccine efficacy; reducing the number of animals used in vaccine development; and investigating the discrepancies in how vaccines work in different population groups.

 

Agenda

 

11:00-11:10 Introduction and welcome
11:10-12:00 How IMI projects have impacted vaccines research
12:00-12:25 Questions and answers
12:25-12:30 Closing remarks

 

 

Session recording and presentation

 

Meet the speakers
alt
Dr Ole F. Olesen

Executive Director

European Vaccine Initiative

alt
Dr Dimitri Diavatopoulos

Associate Professor

Radboud University Medical Center

alt
Laurence Torcel-Pagnon

Global Medical Evidence Generation Lead for Influenza

Sanofi Vaccines

alt
Javier Díez-Domingo

Head of the Vaccine Research Department

FISABIO

alt
Tek-Ang Lim

Scientific Project Officer

IHI - Event moderator